rs1554337424
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_017654.4(SAMD9):c.132delA(p.Val45SerfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. A44A) has been classified as Likely benign.
Frequency
Consequence
NM_017654.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- MIRAGE syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- normophosphatemic familial tumoral calcinosisInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- monosomy 7 myelodysplasia and leukemia syndrome 2Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SAMD9 | ENST00000379958.3 | c.132delA | p.Val45SerfsTer2 | frameshift_variant | Exon 3 of 3 | 1 | NM_017654.4 | ENSP00000369292.2 | ||
| SAMD9 | ENST00000620985.4 | c.132delA | p.Val45SerfsTer2 | frameshift_variant | Exon 2 of 2 | 2 | ENSP00000484636.1 | |||
| SAMD9 | ENST00000446617.1 | c.132delA | p.Val45SerfsTer2 | frameshift_variant | Exon 2 of 2 | 2 | ENSP00000414529.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Normophosphatemic familial tumoral calcinosis Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at